Operating Expenses: The sum of all operating expenses for the given industry.
Sanofi (SNY) had Operating Expenses of $11.07B for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$15.39B |
|
$3.28B |
|
$3.99B |
|
$11.41B |
|
|
Operating Expenses |
$11.07B |
$4.32B |
|
$-218.58M |
|
$4.10B |
|
$4.12B |
|
$3.31B |
|
$3.31B |
|
$3.28B |
|
$3.33B |
|
$4.32B |
|
$4.32B |
|
2.44B |
|
2.44B |
|
$1.34 |
|
$1.34 |
|
| Balance Sheet Financials | |
$39.79B |
|
$11.34B |
|
$111.92B |
|
$151.72B |
|
$37.53B |
|
$13.68B |
|
$28.24B |
|
$65.76B |
|
-- |
|
$5.45B |
|
$85.95B |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.06 |
|
-- |
|
-- |
|
0.14 |
|
0.27 |
|
74.09% |
|
28.07% |
|
28.07% |
|
-- |
|
26.65% |
|
21.28% |
|
-- |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.14 |
|
26.50 |
|
3.40 |
|
-- |
|
60.61% |
|
2.18% |
|
3.32% |
|
-- |
|
-- |
|
-- |
|